v3.26.1
Stock Options and Warrants
3 Months Ended
Mar. 31, 2026
Stock Options and Warrants [Abstract]  
Stock Options and Warrants

Note 14 – Stock Options and Warrants

 

The following table summarizes the options outstanding, option exercisability and the related prices for the shares of the Company’s common stock issued to employees and consultants under a stock option plan at March 31, 2026:

 

    Options Outstanding   Options Exercisable 
Exercise Prices ($)   Number
Outstanding
   Weighted
Average
Remaining
Contractual
Life
(Years)
   Weighted
Average
Exercise
Price ($)
   Number
Exercisable
   Weighted
Average
Exercise
Price ($)
 
$2.38            1,200,000    4.46   $        2.38    
         -
   $
             -
 

 

The stock option activity for the three months ended March 31, 2026 is as follows:

 

   Options   Weighted Average
Exercise Price
 
Outstanding at December 31, 2025   1,200,000   $2.38 
Granted   
-
    
-
 
Exercised   
-
    
-
 
Expired or canceled   
-
    
-
 
Outstanding at March 31, 2026   1,200,000   $2.38 
Exercisable at March 31, 2026   
-
   $
-
 

Stock-based compensation expense related to vested options was $116,307 during the three months ended March 31, 2026 and is recognized utilizing the straight-line method. Stock options outstanding as of March 31, 2026, as disclosed in the above table, have an intrinsic value of $0. Stock options exercisable as of March 31, 2026, as disclosed in the above table, have an intrinsic value of $0. As of March 31, 2026, unamortized stock-based compensation costs related to options was $1,144,243 and will be recognized over a period of 2.5 years.

 

The following table summarizes the changes in warrants outstanding and the related prices for the shares of the Company’s common stock issued at March 31, 2026:

 

    Warrants Outstanding   Warrants Exercisable 
Exercise Price ($)   Number
Outstanding
   Weighted
Average
Remaining
Contractual
Life (Years)
   Weighted
Average
Exercise
Price  ($)
   Number
Exercisable
   Weighted
Average
Exercise
Price ($)
 
$0.00001–11.70    3,156,000    3.16   $0.43    156,000   $8.69 

 

The warrant activity for the three months ended March 31, 2026 is as follows:

 

   Warrants   Weighted
Average
Exercise
Price
 
Outstanding at December 31, 2025   156,000   $8.69 
Granted   3,000,000    0.00001 
Exercised   
-
    
-
 
Expired or canceled   
-
    
-
 
Outstanding at March 31, 2026   3,156,000   $0.43 
Exercisable at March 31, 2026   156,000   $8.69 

  

Stock warrants outstanding as of March 31, 2026, as disclosed in the above table, have an intrinsic value of $3,869,970. Stock warrants exercisable as of March 31, 2026, as disclosed in the above table, have an intrinsic value of $0.